OverviewChartTechnicalNewsTraderScreen

Psychemedics Corporation/  US7443752057  /

NASDAQ
10/10/2024  9:50:57 PM Chg. 0.0000 Volume Bid10:00:00 PM Ask10:00:00 PM High Low
2.3100USD 0.00% 1,990
Turnover: 3,048.1050		 2.3000Bid Size: 1,000 2.3300Ask Size: 600 2.3200 2.3100
GlobeNewswire 8/29 Psychemedics Corporation Launches New Ketamine Hair Testing Service
GlobeNewswire 8/13 Psychemedics Corporation Reports Second Quarter 2024 Financial Results
GlobeNewswire 8/12 Psychemedics Corporation’s Board of Directors Approves Plan to Terminate Registration of Its Common ...
GlobeNewswire 6/21 Psychemedics Unveils Inaugural Insights Report: Revealing Drug Trends Through Hair Testing
GlobeNewswire 5/14 Psychemedics Corporation Reports First Quarter 2024 Financial Results
GlobeNewswire 3/28 Psychemedics Corporation Reports 2023 Financial Results
GlobeNewswire 3/21 Psychemedics Recognized as a Top 10 Employee Health Testing Services Provider
GlobeNewswire 1/2 Psychemedics Corporation Announces Relocation of Headquarters to Dallas, Texas
GlobeNewswire 11/27/2023 Psychemedics Corporation Appoints Daniella Mehalik as VP - Finance
GlobeNewswire 11/9/2023 Psychemedics Corporation Reports Third Quarter 2023 Financial Results
GlobeNewswire 10/27/2023 Unveiling the Future of Drug Testing: Psychemedics Introduces Advanced 5-Panel Drug Screen
GlobeNewswire 9/21/2023 Psychemedics Corporation Appoints Shannon Shoemaker as Chief Revenue Officer
GlobeNewswire 8/18/2023 Psychemedics Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire 3/22/2022 Psychemedics Corporation Welcomes Drew Reynolds to Its Board of Directors and Announces the Retireme...
GlobeNewswire 12/10/2021 Psychemedics Corporation Declares Cash Dividend
GlobeNewswire 11/12/2021 Psychemedics Corporation Reports Stronger Revenue, Operating Profit and Earnings Growth in Third Qua...
GlobeNewswire 8/10/2021 Psychemedics Corporation Reports Stronger Second Quarter 2021 Financial Results
GlobeNewswire 5/10/2021 Psychemedics Corporation Reports First Quarter 2021 Financial Results
GlobeNewswire 3/23/2021 Psychemedics Corporation Reports Fourth Quarter and Full Year 2020 Financial Results
GlobeNewswire 3/17/2021 Robyn C. Davis Joins Psychemedics Board of Directors
GlobeNewswire 1/26/2021 Andrew Limbek Joins Psychemedics Corporation as Vice President, Controller
GlobeNewswire 12/17/2020 Sarah Ashby Rejoins Psychemedics Corporation as Vice President, General Counsel
GlobeNewswire 11/9/2020 Psychemedics Announces Third Quarter Results
GlobeNewswire 8/12/2020 Psychemedics Announces Second Quarter Results
GlobeNewswire 5/13/2020 Psychemedics Announces First Quarter Results